Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Two treatments for muscle-related TMJ pain

Official title: Evaluation of Two Treatment Modalities for Myogenous Temporomandibular Disorders: A Randomized Controlled Trial

Run by Alexandria University · NCT07351812 · Data updated 2026-11-12

This trial will try a mouth stabilization appliance and a new ear stent to see which better reduces muscle-related jaw pain in people with myogenous TMD.

More Temporomandibular Disorders (TMD) trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment32 (estimated)
SponsorAlexandria University
Academic / other
Locations1 site (Alexandria)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJune 1, 2026
Study endsJune 1, 2026
Registry record updatedJanuary 20, 2026
Trial IDNCT07351812 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with myogenous TMD who report at least moderate jaw muscle pain (≥4/10), have fully dentate type I occlusion, and no neurological or uncontrolled systemic disease are ideal candidates.

Probably not a fit

People with joint-related (arthrogenous) TMD, clicking or crepitation, prior TMD treatment, recent trauma, certain systemic or neurologic disorders, or recent injections/neck surgery are unlikely to benefit from these specific interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized clinical trial comparing a conventional intraoral stabilization appliance with a recently introduced ear stent for patients diagnosed with myogenous temporomandibular disorder. Eligible participants have at least moderate jaw muscle pain (≥4/10 on the NRS), fully dentate type I occlusion, and no neurological or systemic contraindications; arthrogenous cases are excluded by MRI. Participants will be randomly assigned to one of the two devices and followed for changes in pain and related jaw function. The goal is to determine which noninvasive modality provides greater symptomatic relief for muscle-related TMD.

Why it matters

Potential benefit: If successful, one of these simple, noninvasive devices could provide better pain relief and improved daily function for people with muscle-related TMJ pain.

How similar studies have gone: Stabilization appliances are widely used with supporting evidence for TMD, while the ear stent is a newer device with limited prior data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants presenting with pain score grading at least 4 out of 10 on NRS.
* Participants with fully dentate type I occlusion.
* Patients experiencing no neurological disorders.

Exclusion Criteria:

* Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Imagining (MRI)
* Patients who have clicking or crepitation.
* Previous history of TMD treatment.
* History of recent trauma.
* The presence of systemic diseases (i.e., rheumatoid arthritis, osteoarthritis myologic or arthrological disease).
* Vascular disease (migraine and hypertension).
* Participants with uncontrolled systemic disease (diabetes), hematologic or neurologic disorders or inflammatory diseases.
* Patients who: Underwent trigger point myofascial injection, intramuscular stimulation, or dry needling in the last six months or Underwent neck and/or shoulder surgery in the last year.

Where it's running

  • Alexandria Faculty of Dentistry
    Alexandria, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.